Vaxcyte Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +64.7% | -2.5% | +42.6% | +96.4% | -8.7% | +8.8% | -2.3% | +1.8% | +2.5% | +3.3% | +18.9% | +4.9% | +12.5% | +29.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -126.9% | – | – | – | – | – | – | – | -217.3% | – | – | |
| – | -21.1% | -3.4% | +39.0% | +81.7% | -25.2% | -9.7% | -10.7% | +17.7% | +2.3% | +15.7% | +13.0% | +37.3% | +21.4% | +23.9% | +8.3% | +12.5% | +25.2% | +34.0% | +6.9% | -9.2% | +39.0% | -11.1% | +14.3% | +10.9% | +31.1% | +8.1% | +15.3% | +29.2% | -14.4% | – | |
| – | +72.0% | +10.9% | -2.1% | +33.5% | -7.2% | +60.8% | -2.2% | +22.8% | +3.3% | +7.3% | +3.8% | +11.4% | +24.8% | +15.7% | +9.7% | +9.7% | +10.3% | +7.9% | +12.3% | +13.5% | +8.0% | +7.1% | +24.2% | +14.4% | -1.9% | +1.3% | -0.7% | +2.6% | +5.6% | – | |
| – | -12.3% | -1.2% | +31.1% | +74.2% | -23.1% | +0.4% | -8.7% | +19.0% | +2.5% | +13.6% | +10.7% | +31.4% | +22.1% | +22.3% | +47.8% | -17.8% | +22.4% | +29.7% | +74.0% | -41.8% | +33.6% | -8.5% | +15.9% | +11.5% | +22.4% | +9.6% | +15.2% | +21.7% | -10.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -15.4% | -18.2% | -22.2% | +0.0% | +528.6% | -25.0% | -57.6% | +335.7% | -88.5% | +1,185.7% | -84.4% | +857.1% | -98.5% | +59,400.0% | +457.4% | +61.8% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +511.3% | -41.6% | -21.2% | -99.0% | – | – | – | – | – | +42.9% | – | – | – | -202.2% | – | -178.6% | – | -208.8% | – | -232.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.